These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32291095)

  • 1. A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis.
    Goh SW; Jamil A; Safian N; Md Nor N; Muhammad N; Saharudin NL
    An Bras Dermatol; 2020; 95(3):320-325. PubMed ID: 32291095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind placebo-controlled cosmetic trial of a topical first-in-class Neutraligand targeting the chemokine TARC/CCL17 in mild-to-moderate atopic dermatitis.
    Frossard N; Coïc A; Saguet T; Coïc A; Himbert F; Do QT; Galzi JL; Suehs C; Guillaumet G; Bonnet P; Bernard P
    Int J Cosmet Sci; 2024 Jun; 46(3):468-477. PubMed ID: 38326978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Moisturizer Meaningfully Reduces Disease Severity in Atopic Patients With Xerosis.
    Kelly KA; Cook MK; Singh R; Perche PO; Balogh EA; Richardson IM; Feldman SR
    J Drugs Dermatol; 2023 Dec; 22(12):e51-e52. PubMed ID: 38051832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of atopic dermatitis in high-risk neonates via different types of moisturizer application: A randomized, blinded, parallel, three-group, phase II trial (PAF study).
    Inuzuka Y; Yamamoto-Hanada K; Kobayashi T; Pak K; Toyokuni K; Ogita H; Miyoshi T; Ogawa K; Sago H; Ohya Y
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2526-2536. PubMed ID: 37478291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence.
    Hebert AA; Rippke F; Weber TM; Nicol NH
    Am J Clin Dermatol; 2020 Oct; 21(5):641-655. PubMed ID: 32524381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Pseudoceramide Moisturizer in Patients with Mild-to-Moderate Atopic Dermatitis.
    Seghers AC; Cai SC; Ho MS; Giam YC; Tan L; Grönhagen CM; Tang MB
    Dermatol Ther (Heidelb); 2014 Jun; 4(1):83-92. PubMed ID: 24619816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to "Correspondence on Evaluation of a paraffin based moisturizer compared to a ceramide based moisturizer in children with atopic dermatitis: A double-blind, randomized controlled trial".
    Gupta S; Ramam M; Sharma VK; Sethuraman G; Pandey RM; Bhari N
    Pediatr Dermatol; 2024; 41(3):565. PubMed ID: 38743459
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial.
    Muhammad P; Novianto E; Setyorini M; Legiawati L; Yusharyahya SN; Menaldi SL; Budianti WK
    Arch Dermatol Res; 2024 Jun; 316(6):329. PubMed ID: 38829483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-analysis Comparing Topical Corticosteroids With Vehicle/Moisturizer in Childhood Atopic Dermatitis.
    Fishbein AB; Mueller K; Lor J; Smith P; Paller AS; Kaat A
    J Pediatr Nurs; 2019; 47():36-43. PubMed ID: 31026679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of a Topical Anti-Inflammatory Drug and a Moisturizer, Both with a Lamellar Structure Containing Synthetic Pseudo-Ceramides, for the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis.
    Okoshi K; Ito S; Matsuoka M; Kinugasa Y; Shimizu E; Tanaka K; Okada J; Nishizaka T; Nagasawa A; Seki T; Iijima M; Abe M; Nemoto O
    Clin Cosmet Investig Dermatol; 2024; 17():1569-1578. PubMed ID: 38974707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on "Evaluation of a paraffin-based moisturizer in children with atopic dermatitis: A double-blind, randomized controlled trial".
    Hernandez LE; Schachner LA
    Pediatr Dermatol; 2024; 41(2):374-375. PubMed ID: 38494774
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blinded, randomized, split-side, vehicle-controlled study of the efficacy of cleanser containing Acanthus ebracteatus Vahl., Suregada multiflora, and Acacia concinna in patients with atopic dermatitis: A pilot study.
    Winayanuwattikun W; Varothai S; Tuchinda P; Kulthanan K; Prasertworonun N; Dasri P; Wanichthanarak K; Akarasereenont P
    Asian Pac J Allergy Immunol; 2023 Dec; 41(4):304-310. PubMed ID: 33068366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild-to-moderate atopic dermatitis: A randomized, double-blind, vehicle-controlled trial.
    Kim MS; Kim HJ; Kang SM; Heo YM; Kang J; Ryu TK; Kim HJ; Choi YB; Kim S; Nho YH; Kang S; Smith L; Koyanagi A; Papadopoulos NG; Jo H; Lee DG; Shin JU; Yon DK
    Allergy; 2024 Jun; 79(6):1612-1616. PubMed ID: 38436460
    [No Abstract]   [Full Text] [Related]  

  • 14. Maintenance of an Acidic Skin Surface with a Novel Zinc Lactobionate Emollient Preparation Improves Skin Barrier Function in Patients with Atopic Dermatitis.
    Andrew PV; Pinnock A; Poyner A; Brown K; Chittock J; Kay LJ; Cork MJ; Danby SG
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):391-408. PubMed ID: 38175365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, comparative clinical pilot study of cold atmospheric plasma device in the treatment of atopic dermatitis.
    Kim YJ; Lim DJ; Lee MY; Lee WJ; Chang SE; Won CH
    Sci Rep; 2021 Jul; 11(1):14461. PubMed ID: 34262113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals: Evaluation of their impact on skin barrier function.
    Vitek M; Matjaž MG
    Acta Pharm; 2024 Jun; 74(2):301-313. PubMed ID: 38815204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study.
    Gargiulo L; Ibba L; Bianco M; Di Giulio S; Alfano A; Cascio Ingurgio R; Facheris P; Perugini C; Valenti M; Costanzo A; Narcisi A
    J Dermatolog Treat; 2024 Dec; 35(1):2375102. PubMed ID: 38964753
    [No Abstract]   [Full Text] [Related]  

  • 18. Image Analysis of Xerosis and Atopic Dermatitis Following Prebiotic Skincare Regimen in Ethnically Diverse Patients.
    Dumbuya H; Draelos ZD; Cassar E; Peucat C; Floc'h CL; Podimatis K
    J Drugs Dermatol; 2024 Jul; 23(7):557-563. PubMed ID: 38954628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revitalizing the skin: Exploring the role of barrier repair moisturizers.
    Madnani N; Deo J; Dalal K; Benjamin B; Murthy VV; Hegde R; Shetty T
    J Cosmet Dermatol; 2024 May; 23(5):1533-1540. PubMed ID: 38214440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and treatment patterns of ruxolitinib 1.5% cream in adult atopic dermatitis: A single center retrospective study.
    Stefanko NS; Quan VL; Chovatiya R
    J Am Acad Dermatol; 2023 Aug; 89(2):415-417. PubMed ID: 37094652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.